R. Rodriguez

The Novel IKK 2 Inhibitor LY 2409881 Potently Synergizes with Histone Deacetylase Inhibitors in Preclinical Models of Lymphoma through the Downregulation of NFk B

W. Tsai, C. Deng, O. O’Connor, 2014 .

Title: the Novel Ikk2 Inhibitor Ly2409881 Potently Synergizes with Histone Deacetylase Inhibitors in Preclinical Models of Lymphoma through the Downregulation of Nf-kb Authors and Affiliations

W. Tsai, Christine, C. Deng, 2022 .

V-abl confers resistance and growth advantage to TNF-α in NIH3T3 cells

M. Hung, J. Klostergaard, T. Suen, 1990 .

The PI3K Delta Inhibitor TGR-1202 and Proteasome Inhibitor Carfilzomib Are Highly Synergistic In Killing Human B- and T-Cell Lymphoma Cells

C. Deng, O. O’Connor, S. Viswanadha, 2013 .

The Novel IKK2 Inhibitor LY2409881 Potently Synergizes with Histone Deacetylase Inhibitors in Preclinical Models of Lymphoma through the Downregulation of NF-κB

W. Tsai, C. Deng, O. O’Connor, 2014, Clinical Cancer Research.

Combination Of Selective HDAC Inhibitors That Target Specific HDAC Isoforms Synergistically Inhibits T Cell Lymphoma

O. O’Connor, E. Holson, Charles Karan, 2013 .

UTX functions as a tumor suppressor and as an epigenetic regulator of gene

R. Rodriguez, 2023 .